Mike Shirota, founder and CEO of Mushroom Wisdom, Inc. (East Rutherford, NJ) announced that the company has been granted a patent of its exclusive proprietary extract of Lion’s Mane (Hericium erinaceus) called Amycenone, which is featured in its branded product Amyloban 3399.

The U.S. Patent, number 8,871,492, issued in October, officially recognizes the company’s unique method of extraction that ensures efficacious strength and safety while supporting healthy brain function, reported the company.

“The dietary supplement industry, both raw material and finished products, continues to become more scientifically grounded as customers become more educated, knowledgeable and motivated to support their health through conscious supplementation,” said Donna Noonan, president, Mushroom Wisdom Inc. “Securing a patent such as this is testament to the profound work scientists, researchers, and practitioners do and we hope serves to engender greater trust among customers.”

Amyloban 3399 contains a bioactive fat-soluble fraction, amyloban – derived from Lion’s Mane, shown to support nerve cell health. It also contains a class of active compounds known as hericenomes, also from Lion’s Mane, that research demonstrates a protective action for supporting healthy brain, according to the company. It was developed by the Mushroom Wisdom research team in collaboration with leading university researchers in Japan, and is offered in vegetarian tablets.

For more information, visit www.mushroomwisdom.com.